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Summary
 
After antigen capture, dendritic cells (DC) migrate into T cell–rich areas of secondary lym-
phoid organs, where they induce T cell activation, that subsequently drives B cell activation.
Here, we investigate whether DC, generated in vitro, can directly modulate B cell responses,
using CD40L-transfected L cells as surrogate activated T cells. DC, through the production of
soluble mediators, stimulated by 3- to 6-fold the proliferation and subsequent recovery of B cells.
Furthermore, after CD40 ligation, DC enhanced by 30–300-fold the secretion of IgG and IgA
by sIgD
 
2
 
 B cells (essentially memory B cells). In the presence of DC, naive sIgD
 
1
 
 B cells pro-
duced, in response to interleukin-2, large amounts of IgM. Thus, in addition to activating na-
ive T cells in the extrafollicular areas of secondary lymphoid organs, DC may directly modulate
B cell growth and differentiation.
 
A
 
t the antigen/pathogen port of entry (e.g., mucosa,
epidermis), dendritic cells (DC)
 
1
 
, such as Langerhans cells
(LC), capture the antigen and then migrate via the afferent
lymphatics into the T cell–rich areas of regional lymph nodes,
where they are called interdigitating dendritic cells (IDC) (for
review see reference 1). There, they present processed anti-
gen to naive T cells and generate an antigen-specific pri-
mary T cell response. Once primed by DC, T cells can
promote B cell activation, both by releasing T cell–derived
cytokines such as IL-2, IL-4, and IL-5, and by direct inter-
cellular contacts (for review see reference 2). Among the
signals involved in T/B cell cooperation, the interaction
between CD40 (on B lymphocytes) and its ligand (CD40L)
expressed on activated T cells, appears to be of critical im-
portance (for review see reference 3). CD40, a molecule
related to the TNF receptor family, is expressed on multi-
ple cell types, including mature B cells and bone marrow–
derived DC (4). Cross-linking of CD40 promotes B cell
survival (5) proliferation (6) as well as B cell differentiation
and immunoglobulin class switching (7, 8). The ligand for
CD40, CD40L, is a TNF family member expressed on ac-
tivated but not resting T cells (9). The importance of
CD40/CD40L pathway in B cell immunopoiesis has been
demonstrated in vivo in patients with X-linked hyper IgM
syndrome (for review see reference 10).
The role of DC in humoral responses has been docu-
mented in vitro (11) and in vivo (12–15). Notably, DC in-
cubated in vitro with antigen can induce, upon reinjection
into mice, a protective humoral response (15). The critical
role of DC in induction of humoral responses is viewed as
a consequence of T cell priming, required for cognate in-
teraction between T cells and B cells. However, as the
primary B cell activation occurs within the extrafollicular
T cell–rich areas (16), we wondered whether, in addition to
priming T cells, DC were able to interact directly with B cells.
Accordingly, we set up a system in which a CD40L-trans-
fected murine cell line (CD40L L cells) was used as surro-
gate activated T cells, to study the effects of DC on B cell
activation. Recent studies have indicated the possibility of
generating large numbers of DC in vitro starting either from
unseparated blood or bone marrow populations or from
purified CD34
 
1
 
 hematopoietic progenitors (17). DC, gen-
erated by culturing human CD34
 
1
 
 hematopoietic progeni-
tors with GM-CSF and TNF
 
a
 
 have been shown earlier to
induce a strong proliferation of allogeneic T cells (18, 19)
and to express a functional CD40, the triggering of which
induces their maturation into cells with characteristics of
IDC (20). These in vitro–generated DC have been shown
to contain LC as well as other DC related to dermal DC
and thus were termed dendritic–Langerhans cells (D–Lc) (21).
Here, we demonstrate that D–Lc can strongly enhance
both proliferation and Ig production of CD40-activated
naive and memory B cells. These results suggest that DC
might directly be involved in the extrafollicular plasma cell
formation during induction of primary naive B cell re-
sponses or reactivation of secondary memory B cell re-
sponses.
 
1
 
Abbreviations used in this paper:
 
 DC, dendritic cells; D–Lc, dendritic–
Langerhans cells; GC, germinal center; IDC, interdigitating dendritic cells.
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Materials and Methods
 
Reagents and Cell Lines.
 
Cultures of CD34
 
1
 
 progenitors were
established in RPMI-1640 (GIBCO BRL, Gaithersberg, MD)
supplemented with 10% (vol/vol) FCS, 10 mM Hepes, 2 mM
 
l
 
-glutamine, 5 
 
3
 
 10
 
2
 
2
 
 M 2-mercaptoethanol, and 0.08 
 
m
 
g/ml
gentamycine (gentalline; Schering Plough, Levallois Perret, France),
which will be referred to as complete RPMI. Cultures of B lym-
phocytes were carried out in modified Iscove’s medium, supple-
mented with 10% inactivated FCS (MultiSer, Castell Hill, NSW),
2 mM 
 
l
 
-glutamine (GIBCO BRL, Gaithersberg, MD) and 0.08
 
m
 
g/ml gentamycine.
The murine CD40 L-transfected cell line (CD40L L cells) was
produced in the laboratory as described earlier (22) and used as
stimulator of B cell proliferation and differentiation. Mouse fibro-
blastic L cells stably transfected with the human CD32/Fc
 
g
 
RII
have been previously described (23). A chimeric fusion protein
between the mouse CD8-
 
a
 
 and the human CD40 T cell ligand
was constructed in our laboratory as previously reported (22) and
produced in COS cells.
rhGM-CSF (specific activity: 2 
 
3
 
 10
 
6
 
 U/mg; Schering Plough
Research Institute, Kenilworth, NJ) was used at a saturating con-
centration of 100 ng/ml (200 U/ml). rhTNF-
 
a
 
 (specific activity,
2 
 
3
 
 10
 
6
 
 U/mg; Genzyme, Boston, MA) was used at an optimal
concentration of 2.5 ng/ml (50 U/ml). Purified rhIL-2 (5 
 
3
 
 10
 
4
 
U/mg) from Amgen (Thousand Oaks, CA) was used at 20 U/ml.
Purified rhIL-4 and rhIL-10 (10
 
7
 
 U/mg each; Schering Plough
Research Institute, Kenilworth NJ) were used at 50 U/ml and 20
ng/ml, respectively.
 
Generation of D–Lc.
 
Umbilical cord blood samples were ob-
tained according to institutional guidelines. Cells bearing CD34
antigen were isolated from mononuclear fractions through posi-
tive selection, using anti-CD34 mAb (10 
 
m
 
g/ml; Immu-133.3;
Immunotech Marseille, France) and goat anti–mouse IgG-coated
microbeads (Miltenyi Biotec GmBH, Bergish Gladbach, Ger-
many). Isolation of CD34
 
1
 
 progenitors was achieved using Mini-
macs separation columns (Miltenyi Biotec) (21).
Cultures were established in the presence of GM-CSF and
TNF-
 
a
 
 in complete RPMI. CD34
 
1
 
 cells were seeded for expan-
sion in 24-well culture plates (Limbro, Flow Laboratories, McLean,
VA) at 2 
 
3
 
 10
 
4
 
 cells/ml. Optimal conditions were maintained by
splitting these cultures every 4–5 d. Cells were routinely collected
at day 12 when the cultures contained between 70–90% of
CD1a
 
1
 
 DC (18, 21). These CD1a
 
1
 
 cells includes LC that express
Birbeck granules as well as other DC and thus will be referred to
as D–Lc throughout the text (21). The CD1a
 
2
 
 population in-
cludes granulocytes, monocytes, undifferentiated precursors and,
in some instances, mature DC that have lost CD1a.
For certain experiments, after 12 d of culture in the presence
of GM-CSF and TNF-
 
a
 
, cells generated from CD34
 
1
 
 progeni-
tors were collected and labeled with FITC-conjugated OKT6
(CD1a; Ortho Diagnostic). Cells were separated according to
CD1a expression into CD1a
 
2
 
 and CD1a
 
1
 
 fractions using a FAC-
Star
 
Ò
 
 (Becton Dickinson, Mountain View, CA). The procedure
of staining and sorting was performed in the presence of 5 mM
EDTA in order to avoid cell aggregation. Reanalysis of the sorted
populations showed a purity higher than 98%.
 
Isolation of Tonsillar B Cells.
 
Mononuclear cells from tonsils
were isolated by a standard Ficoll–HyPaque (dose 
 
5
 
 1,077 g/ml)
gradient method. Tonsillar B cells were first enriched in the
E
 
2
 
 fraction and submitted to anti-CD2, anti-CD4, anti-CD8, anti-
CD14, anti-CD16 mAb negative selection with magnetic beads
coated with anti-mouse IgG (Dynabeads; Dynal, Oslo, Norway).
In the isolated population, 
 
.
 
99% expressed CD19 and CD20 and
 
,
 
1% expressed CD2 or CD14 antigens. Isolation of sIgD
 
1
 
 and
sIgD
 
2
 
 B cells subpopulations was performed using a preparative
magnetic cell sorter (MACS; Becton Dickinson) (24). IgD was
expressed on 
 
.
 
99% of the sIgD
 
1
 
 B cell subpopulation and 
 
,
 
1%
of sIgD
 
2
 
 B cell subpopulation, as assessed by fluorescence analysis
using a FACScan
 
Ò
 
 (Becton Dickinson). For certain experiments,
sIgD
 
2
 
 B cells were further separated according to CD38 and CD39
expression into CD38
 
1
 
CD39
 
2
 
 germinal center (GC) cells and
CD38
 
2
 
CD39
 
1
 
 memory B cells using anti-CD38 and anti-CD39
mAbs and bead depletion as described earlier (25).
In some experiments, total B cells were separated according to
their size using a discontinuous gradient of Percoll (Pharmacia,
Uppsala, Sweden) as described earlier (22). B cells recovered at the
interface of 35–55% layers were referred to as low density B cells, and
cells recovered at the interface of 65–55% Percoll solutions were
referred to as high density or resting B cells. In some cases, resting
B cells were further labeled with FITC-conjugated anti-CD20, PE-
conjugated anti-CD38 (Becton Dickinson) and biotinylated anti-
IgD (Sigma), followed by incubation with Streptavidin–Tricolor
(Kallestad, Austin, TX) and sorted into CD20
 
1
 
IgD
 
1
 
CD38
 
2
 
 na-
ive B cells and CD20
 
1
 
IgD
 
2
 
CD38
 
2
 
 memory B cells (25). Reanal-
ysis of the sorted populations showed a purity higher than 99%.
 
Isolation of Human Monocytes.
 
Total PBMC were isolated from
healthy donors by Ficoll–HyPaque centrifugation; monocytes
were isolated by elutrial centrifugation as described elsewhere (26).
The preparation was 
 
.
 
90% pure as controlled by flow cytometry
with FITC-conjugated anti CD14 (Leu-M3; Becton Dickinson).
 
Coculture of B Cells and D–Lc.
 
2.5 
 
3
 
 10
 
3
 
 irradiated CD40L L
cells (7,500 rads) were seeded together with 10
 
4
 
 B lymphocytes
(either total B cells or B cells subpopulations) in the presence or
absence of in vitro generated D–Lc (10
 
4
 
) in 96-well culture plate
(Nunc, Roskilde, Denmark). B cell proliferation was monitored
by tritiated thymidine ([
 
3
 
H]TdR) incorporation after 6 d of co-
culture, except for kinetic experiments. Cells were incubated for
the last 16 h with 1 
 
m
 
Ci of [
 
3
 
H]TdR. Tests were carried out in
triplicate, and results were expressed as cpm 
 
6
 
 SD. For determi-
nation of Ig production, supernatants were recovered after 15 d
and used for indirect ELISA (27). For Giemsa stainings and im-
munostainings, 10
 
5
 
 B cells were cultured together with 10
 
5
 
 irradi-
ated D–Lc over 2.5 
 
3
 
 10
 
4
 
 irradiated CD40L L cells in a final vol-
ume of 1 ml in 24-well culture plates. After 6 d of culture, cells
were gently harvested and used for staining experiments.
In other experiments, B cells and D–Lc were cultured in sepa-
rate compartments using transwells (Costar, Wilmington, MA).
10
 
5
 
 D–Lc cultured in the presence or absence of CD40 triggering
(2.5 
 
3
 
 10
 
4
 
 CD40L L cells or CD32 L cells used as control) in the
lower compartment (in a total volume of 0.8 ml) were assayed for
their ability to stimulate growth and differentiation of 1.5 
 
3
 
 10
 
4
 
B cells activated by 3.75 
 
3
 
 10
 
3
 
 CD40L L cells or control CD32
L cells in the top of the transwells (in a total volume of 0.2 ml).
DNA synthesis of B cells was performed by transferring, at day 6,
the cells present in the top of the transwells into flat-bottomed
96-well plates and pulsing them with [
 
3
 
H]TdR for the last 16 h of
the culture period.
Control phenotype of the cultures was routinely performed
using FITC-labeled anti-CD3 and anti-CD19 (Immunotech) and
FITC-labeled IgG1 (Kallestad).
 
Giemsa and Immunostainings.
 
Cells from cocultures of B cells
and D–Lc over CD40L L cells were cytocentrifuged for 5 min at
500 rpm on microscope slides. Some slides were used for May-
Grünwald-Giemsa staining and the others were fixed either in cold
acetone or 4% paraformaldehyde during 10 min for immunocy- 
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tology. Single stainings were performed using the alkaline phos-
phatase–anti-alkaline phosphatase system (APAAP technique) with
mouse anti–HLA-DR (IgG1 from Immunotech) or anti-CD80
(IgG1 from Becton Dickinson) revealed by the Fast Red substrate
(DAKO). Double stainings were performed using the biotin–avi-
din–peroxidase system (mouse IgG2a anti–HLA-DR from Becton
Dickinson) and the APAAP technique (mouse IgG1 anti-CD20
from Becton Dickinson) as described elsewhere (30). Peroxidase
activity was developed by 3-amino-9-ethylcarbazole, which gives
a red color, and alkaline phosphatase activity was developed by
Fast Blue substrate, which gives a blue color.
 
Results
 
D–Lc Enhance the Growth of CD40-activated B Cells.
 
In
early experiments, using allogeneic cord blood DC and
resting tonsillar T cells and B cells, DC were found to induce
the activation of T cells, subsequently resulting in the dif-
ferentiation of B cells as measured by Ig production (Caux, C.,
B. Vanbervliet, and J. Banchereau, unpublished results). Ac-
cordingly, we wondered whether D–Lc generated in vitro
by culturing cord blood CD34
 
1
 
 cells for 12 d in the pres-
ence of GM-CSF and TNF-
 
a
 
 (later on referred to as D–Lc)
(18, 21) could directly modulate B cell responses. Inas-
much as CD40L on activated T cells appears to signal both
B cells and DC, CD40L-transfected L cells (CD40L L cells)
were used as surrogate activated T cells.
The D–Lc preparation used in this study contains 70–
90% CD1a
 
1
 
 as well as CD1a
 
2
 
 cells including granulocytes
and monocytes (see Materials and Methods). The role of
the latter cells will be discussed later on (Fig. 4). As shown
in Fig. 1 
 
A
 
, D–Lc strongly enhanced CD40-induced B cell
proliferation as measured by [
 
3
 
H]TdR uptake after 6 d of
coculture (three to eight-fold enhancement of [
 
3
 
H]TdR
uptake). Note that in the absence of CD40L L cells, D–Lc
can not induce B cell proliferation (Fig. 1 
 
A
 
, 
 
left
 
). Kinetics
analysis shows that addition of 10
 
4
 
 D–Lc to CD40 trigger-
ing resulted in a twofold increase of [
 
3
 
H]TdR incorpora-
tion at day 2, which reached fourfold at day 4, when a pla-
teau is reached (Fig. 1 
 
B
 
). This enhancement of B cell
DNA synthesis by D–Lc is associated to an important in-
crease in number of viable B cells (Fig. 1 
 
C
 
) that reaches a
plateau at day 10, a time when D–Lc increased B cell num-
Figure 1. In vitro generated D–Lc enhance DNA synthesis and via-
ble cell number of B lymphocytes activated through their CD40. (A) 104
highly purified B cells were cultured over 2.5 3 103 irradiated CD40L L
cells (right) or in medium alone (left) in the presence or absence of 104 ir-
radiated D–Lc, as detailed in Materials and Methods. Thymidine uptake,
determined after 6 d, is expressed as mean 6 SD of triplicate cultures. (B)
Kinetic of DNA synthesis of 104 CD40-activated B cells cultured in the
presence or absence of 104 D–Lc was monitored between day 0 and day 8.
(C) For numeration experiments, 5 3 104 highly purified B cells were
cultured over 2.5 3 104 irradiated CD40L L cells in the presence or ab-
sence of 5 3 104 D–Lc in 24-well plates. Viable cell recovery was deter-
mined at many timepoints using Trypan blue dye exclusion between day
0 and day 15. (D) Increasing D–Lc numbers were added to 104 CD40-
activated B cells, and thymidine uptake was determined after 6 d of cocul-
ture (results from experiments representative of 15).
Figure 2. D–Lc strongly enhance Ig production by CD40-activated
memory B cells. B cells were cultured over CD40L L cells in the presence
or absence of D–Lc and their supernatants were harvested after 15 d and
assayed for presence of (A) IgG, IgA, and IgM. (B) Increasing numbers of
D–Lc were added to 104 CD40-activated B cells and total Ig production
was measured after 15 d of coculture. Igs levels are expressed as mean 6
SD of triplicate cultures (results from 1 experiment representative of 10).
(C) B cells were purified into IgD1 B cells and IgD2 B cells using the
MACS system (purification detailed in Materials and Methods). IgD2 B
cells were further separated into CD381CD392 germinal center B cells
(GC) and CD382CD391 memory B cells using mAbs and bead depletion
as detailed in Materials and Methods. Increasing numbers of either total B
cells, MACS purified sIgD1 B cells, GC cells, or memory B cells were
cultured over 2.5 3 103 irradiated CD40L L cells in medium alone or in
the presence of 104 irradiated D–Lc. (SD < 10%). (results from 1 of 3 ex-
periments). No significant B cell proliferation and differentiation was ob-
served in absence of CD40L L cells.944 Functions of Dendritic Cells on B Cells
ber by fivefold. As few as 500 D–Lc are sufficient to induce
a two- to threefold increase of CD40-induced B cell prolif-
eration (Fig. 1 D), a maximal effect being obtained with
104 D–Lc (ratio 1:1). Thus, D–Lc enhance the proliferation
of CD40-activated B cells in absence of any exogenous cy-
tokine.
D–Lc Induce CD40-activated Memory B Cells to Secrete
Igs. To investigate the effect of D–Lc on the differentia-
tion of CD40-activated B cells into Ig-secreting cells, ton-
sillar B cells were cultured over CD40L L cells with or
without D–Lc. In the absence of D–Lc, 104 B cells pro-
duced only marginal amounts of Igs (,0.2 mg/ml; Fig. 2 A).
Addition of 104 D–Lc to CD40-activated B cells results in
the production of microgram amounts of IgG (range, 4–70
mg/ml; mean increase, 125; n 5 12) and IgA (range, 0.8–6
mg/ml; mean increase, 33; n 5 12). In contrast, IgM secre-
tion was increased only 5- to 15-fold (range, 0.5–2 mg/ml;
mean increase, 10; n 5 12). As few as 330 D–Lc induced
an eightfold increase in total Ig secretion, maximal effect
being obtained with 104 D–Lc per well (40-fold increase)
(Fig. 2 B).
Tonsillar B cells consist of naive B cells, expressing sur-
face IgM and IgD as well as GC B cells and memory B cells
that have mostly undergone isotype switch, thus resulting
in a loss of IgD expression (28, 29). Therefore, we analyzed
whether either purified sIgD1 B cells (naive B cells) or
sIgD2 B cells (GC and memory B cells) were preferential
targets for D–Lc effect on IgG and IgA secretions. As
shown in Fig. 2 C, CD40-activated naive sIgD1 B cells did
not produce IgG whether or not D–Lc are added. Separa-
tion of sIgD2 B cells into CD381CD392 GC cells and
CD382CD391 memory B cells (using mAbs and bead de-
pletion) (25), allowed identification of the responding cell
population. As shown in Fig. 2 C, memory B cells repre-
sent the main source of IgG as, when cultured in the pres-
ence of D–Lc, 103 memory B cells produced 5 mg/ml IgG
and 104 27 mg/ml, while GC cells produced ,0.5 mg/ml
and 4 mg/ml, respectively, under such culture conditions.
To exclude that these observations could be the result of
expansion of in vivo–activated B cells, resting and activated
B cells were separated according to their density by Percoll
gradients. As shown in Table 1 (experiment 1), in the ab-
sence of exogenous cytokine, D–Lc enhanced IgG produc-
tion of both resting (high density) and activated (low den-
sity) B cells. Finally, CD201 small resting B cells FACSÒ
sorted into IgD2CD382 cells (resting memory B cells) pro-
duced high levels of IgG, when stimulated with D–Lc (90-
fold enhancement) in the absence of cytokine (Table 1, ex-
periment 2). Similar results were obtained for IgA (data not
shown).
Taken together, these data indicate that, D–Lc induce
CD40-activated memory B cells to secrete considerable
amounts of IgG and IgA.
CD40-activated Naive B Cells Cultured in the Presence of
D–Lc Secrete IgM in Response to IL-2. In view of the weak
stimulation of IgM production, we wondered whether
sIgD1 B cells were sensitive to the stimulatory effect of
D–Lc. As shown in Fig. 3 A and Table 1, D–Lc equally en-
hanced the CD40-induced proliferation of all B cell subsets
(sIgD1, sIgD2, resting, and in vivo-activated B cells) in ab-
sence of any exogenous cytokines. As D–Lc enhanced
growth of naive B cells, we wondered whether addition of
exogenous cytokines could enhance the IgM production
induced by D–Lc. Among the tested cytokines (IL-2, IL-3,
IL-4, IL-6, IL-10, IL-12, IFN-g and their combinations),
only IL-2 yielded significant results. D–Lc did not signifi-
cantly affect the low levels of IgM obtained in response to
IL-4 and the high levels obtained in response to IL-10 (Fig.
Table 1. D–Lc Enhance Growth and Ig Secretion of Resting B Lymphocytes Activated Through CD40
[3H]TdR uptake
(cpm 3 1023) IgG (mg/ml) IgM (mg/ml)
Medium D–Lc Medium D–Lc IL-2 IL-2 1 D–Lc
Exp. 1 Total B cells 7.3 6 0.02 52.4 6 0.1 0.1 6 0.05 23.9 6 0.9 0.1 6 0.02 26.8 6 2.6
Low density 5.6 6 0.06 39.0 6 2.5 0.2 6 0.05 10.9 6 1.2 0.1 6 0.02 16.6 6 1.5
High density 10.0 6 1.6 56.2 6 1.7 0.7 6 0.01 27.5 6 1.0 0.2 6 0.06 41.9 6 5.1
Exp. 2 Total B cells 3.5 6 0.6 17.3 6 0.2 0.5 6 0.01 6.5 6 0.9 0.1 6 0.02 6.0 6 2.0
High density IgD1CD381 3.1 6 0.6 15.4 6 1.7 0.1 6 0.01 0.5 6 0.2 0.3 6 0.1 21.5 6 5.8
High density IgD2CD382 3.5 6 0.2 18.9 6 4.7 0.1 6 0.05 9.0 6 1.2 0.1 6 0.05 0.6 6 0.2
D–Lc stimulate differentiation of resting naive and memory B cells activated through their CD40. Highly purified B cells were separated according
to their size, using Percoll gradients, into low density B cells (activated B cells) and high density B cells (resting B cells). In experiment 1, 104 B cells
were cultured over DC40L L cells in the presence or absence of D–Lc. For expeirment 2, CD201 resting B cells (high density) were further sepa-
rated into IgD1CD382 naive B cells and IgD2CD382 memory B cells, using three-color FACSÒ sorting (as described in Materials and Methods).
These cells were dispensed at 5 3 103/well together with 2.5 3 103 CD40L L cells with or without 104 D–Lc. DNA synthesis was assayed after 6 d
of coculture, and levels of IgG (in the absence of cytokine) and IgM (in the presence of IL-2) were determined at 15 d (1 experiment representative
of 3). No significant B cell proliferation and differentiation was observed in absence of CD40L L cells.945 Dubois et al.
eration, whereas CD1a2 cells were ineffective (Fig. 4 Aa).
In addition, as few as 250 CD1a1 cells induced a 10-fold
increase in IgG production, in absence of exogenous cy-
tokines (Fig. 4 Ab), and in IgM production, in the presence
of IL-2 (Fig. 4 Ac). In contrast, even at high cell density
(104 cells), CD1a2 cells remained ineffective in stimulating
either IgG or IgM production, demonstrating that the de-
scribed stimulatory effects of in vitro–generated D–Lc on B
cells are restricted to CD1a1 D–Lc.
Although highly purified B cells (.99% CD201 cells),
isolated using either bead depletion or cell sorting (Table 1),
were used in all experiments, the presence of IL-2 and
D-Lc, known for their strong capacity to stimulate allore-
active T cells, renders it necessary to exclude a possible
contribution of potentially contaminating T cells. For that
purpose, phenotype of cultured cells was performed rou-
tinely. As an example, Fig. 4 B shows the phenotype of
cells proliferating in cultures performed with total B cells,
D–Lc, CD40L L cells, and IL-2 (the condition that would
most likely allow the outgrowth of contaminating T cells).
No significant outgrowth of CD31 cells can be detected at
any timepoint tested, and .98% of the small cells are
CD191 B cells. Similar results were observed in cultures set
up with sIgD1 B cells and in cultures set up in the absence
of IL-2 (data not shown). D–Lc (high FSC/SSC) were de-
tected during all the culture period (50% at day 0 to ,10%
at day 8). These results support the conclusion that CD1a1
D–Lc can directly enhance the growth and differentiation
of CD40-activated B cells.
D–Lc Are More Efficient than Monocytes in Enhancing
CD40-induced B Cell Differentiation. We compared the ef-
fects of various antigen-presenting cells including D–Lc,
elutriated monocytes (.90% CD14), and lymphoblastoid
cell lines (EBV–LCL) on the proliferation and differentia-
tion of CD40-activated B cells. As shown in Fig. 5 A,
monocytes were as potent as D–Lc in enhancing CD40-
induced B cell proliferation, whereas EBV cell lines were
totally inefficient (only one of the three tested is shown in
Fig. 5). Significant IgG production, in absence of cytokine,
was observed with 3.5 3 102–103 D–Lc, whereas more
than 5 3 103 monocytes were required to observe the same
effects. At higher cell density (104 cells), monocytes in-
duced levels of IgG in the order of 5 mg/ml compared with
17 mg/ml for D–Lc (Fig. 5 B). Concerning the IL-2–depen-
dent IgM production, a significant effect was observed with
less than 450 D–Lc, whereas more than 2.5 3 103 mono-
cytes were required to reach similar levels of IgM secretion.
Thus, whereas D–Lc and monocytes shared an equal ability
to enhance B cell proliferation, D–Lc are more efficient
that monocytes in inducing B cells to secrete IgG and IgM.
The Effect of D–Lc Can Be Obtained in the Presence of Solu-
ble CD40L. To analyze a possible contribution of the fi-
broblastic cell line (CD40L L cells), CD40 activation was
carried out with a soluble form of CD40L using a fusion
protein between the mouse CD8-a and the human CD40L.
The soluble protein was a less efficient activator than the
CD40L L cells (Fig. 6), particularly for proliferation of B
cells, probably reflecting differences in the mode of CD40
Figure 3. In the presence of IL-2, D–Lc strongly enhance IgM produc-
tion by naive sIgD1 B cells. B cells were purified into IgD1 B cells and
IgD2 B cells using the MACS system (purification detailed in Materials
and Methods). Increasing numbers of either total B cells, MACS-purified
IgD1 B cells or IgD2 B cells were cultured under CD40 activation in
medium alone or in the presence of irradiated D–Lc. (A) Cytokine-inde-
pendent proliferation of B cells was measured after 6 d of coculture. (B)
IL-2–dependent IgM production was measured after 15 d. Results are ex-
pressed as mean of triplicate cultures (SD < 10%). (results from 1 experi-
ment representative of 6). (C) 104 highly purified B cells were cultured
over 2.5 3 103 irradiated CD40L L cells in the presence or absence of 103
D–Lc, either in medium alone or with IL-2 (20 U/ml), IL-4 (50 U/ml),
or IL-10 (20 ng/ml). Superposable results were obtained with IgD1 B cells.
Ig levels were determined after 15 d of culture. Results are expressed as
mean 6 SD of triplicate cultures (1 experiment representative of 10). No
significant B cell proliferation and differentiation was observed in absence
of CD40L L cells.
3 C). However, in IL-2 supplemented cultures, addition of
D–Lc induced CD40-activated B cells to secrete high levels
of IgM, which reached 50 mg/ml (mean increase, 161-fold;
n 5 16). Separation of B cells into sIgD1 and sIgD2 B cells
showed that production of IgM was mainly a property of
the naive sIgD1 B cell population (Fig. 3 B). Note, how-
ever, that sIgD2 B cells can be induced to produce signifi-
cant levels of IgM provided 10-fold more B cells (104) are
added to cultures. In addition, results presented in Table 1
show that D–Lc can induce small resting naive B cells (high
density sIgD1CD382 cells) to produce high amounts of
IgM in the presence of CD40 triggering and IL-2.
Thus, D–Lc induce CD40-activated naive B cells to se-
crete high amounts of IgM in response to IL-2.
The Effects of D–Lc on CD40-activated B Cells Are Borne by
the CD1a1 Population and Are Independent of the Outgrowth of
Potentially Contaminating T Cells. Because a population of
D–Lc contains 70–90% CD1a1 cells as well as other cell
types, including granulocytes and monocytes, D–Lc were
FACSÒ sorted into CD1a1 and CD1a2 cells. 104 CD1a1
cells were found to induce a 5-fold increase of B cell prolif-946 Functions of Dendritic Cells on B Cells
cytospins shows close contacts between CD40-activated
B cells and D–Lc (Fig. 7 A). Immunostainings on such cy-
tospins showed large HLA-DR21 CD80high cells with den-
dritic morphology surrounded by HLA-DR21 CD80low B
cells (Fig. 7, B and C). Immunostainings using anti-CD3
mAb failed to detect any positive cells (data not shown).
Double stainings definitely identifies CD40-activated B cells
(CD201/HLA-DRlow) in close contacts with D–Lc (CD202/
HLA-DRhigh), suggesting that these interactions may con-
tribute to the D–Lc-dependent stimulation of B cell growth
and differentiation described in this study.
Experiments were designed to determine whether the
functions of D–Lc on B cells were mediated through solu-
ble factors and/or cell–cell interactions and whether D–Lc
Figure 4. The effects of D–Lc
on CD40-activated B cell are re-
stricted to CD1a1 dendritic cells
and are not due to potentially
contaminating T cells. (A) In
vitro generated D–Lc were
FACSÒ sorted into CD1a2 cells
and CD1a1 DC and used as
stimulators of 104 CD40-acti-
vated B cells. Increasing numbers
of either total D–Lc or FACSÒ
sorted populations were added
to the culture to study (a) the
cytokine-independent prolifera-
tion of B cells, (b) the cytokine-
independent IgG production,
and (c) the IL-2-dependent IgM
production. Results are ex-
pressed as mean of triplicate cul-
tures (SD < 10%). (results from
1 experiment representative of
3). No significant B cell prolifer-
ation and differentiation was ob-
served in absence of CD40L L
cells. (B) The phenotype of cul-
tures consisting of total B cells,
D–Lc, CD40L L cells, and IL-2
was routinely followed during
the culture period. Fluorescence histograms gated on small cells have been obtained with FITC–anti-CD3 and anti-CD19 after exclusion of dead cells us-
ing propidium iodide. High FSC/SSC cells correspond to the D–Lc population.
Figure 5. D–Lc are more efficient than monocytes in enhancing CD40-induced B cell differentiation. D–Lc, one EBV cell line, and elutriated mono-
cytes were compared, after irradiation, in their ability to enhance (A) cytokine-independent CD40-induced B cell proliferation, (B) cytokine-indepen-
dent IgG production, and (C) IL-2–dependent IgM production. Increasing numbers of stimulator cells were added to 104 highly purified B cells cultured
over 2.5 3 103 irradiated CD40L L cells. Results are expressed as mean of triplicate cultures (SD <10%). (results from 1 experiment representative of 3).
No significant B cell proliferation and differentiation was observed in absence of CD40L L cells.
engagement. Yet, addition of D–Lc resulted in enhanced B
cell proliferation (Fig. 6 A) and differentiation (Fig. 6 B).
The effect was particularly remarkable when cytokines,
such as IL-2 or IL-10, were added to the cultures. Thus,
the presence of the fibroblastic line is not mandatory for the
B cell to undergo growth and differentiation in response to
surrogate activated T cells (in the form of soluble CD40L
and recombinant cytokines) and D–Lc.
The Effect of D–Lc on B Cell Activation Is Mediated by Solu-
ble Factor(s): Partial Dependence on CD40 Ligation on D–Lc.
As previously described, B lymphocytes proliferate in clus-
ters over CD40L L cells. Addition of D–Lc enhance the
size and number of these clusters, which include L cells and
D–Lc (data not shown). Giemsa staining on 6-d coculture947 Dubois et al.
had to be activated through their CD40 antigen. Neither
D–Lc supernatants nor fixed D–Lc significantly stimulated
B cell growth and differentiation. As an alternative, D–Lc
were separated from B cells by a permeable membrane us-
ing TranswellsÒ. As shown in Fig. 8 A, D–Lc cultured in
the lower compartment, with or without CD40 triggering,
can enhance CD40-dependent B cell proliferation as much
as if they were cocultured in direct contact. In the presence
of IL-2, CD40-activated D–Lc, but not unactivated D-Lc,
can support IgM production by B cells activated through
CD40 (Fig. 8 B). However, IgM levels obtained were
lower than those observed in direct contact coculture (6.1 6
0.8 mg/ml versus 15.5 6 2.5 mg/ml), suggesting that cell–
cell contacts may also contribute. Note that D–Lc do not
deliver any signal when B cells are not activated (Fig. 8; B
plus CD32 L cells).
Thus, the effect of D–Lc on B cell proliferation appears
to be mediated by soluble factor(s), the production of
which is independent of CD40 engagement on the D–Lc.
In contrast, the effect on B cell differentiation, also medi-
ated through soluble mediator(s), requires CD40 ligation of
the D–Lc.
Discussion
The present study demonstrates that DC can directly pro-
vide signals to CD40-activated B cells, leading to enhanced
proliferation as well as differentiation. To our knowledge,
this study represents the first study demonstrating a direct
effect of DC on normal B lymphocytes. Such information
represents an important complement to studies performed
earlier with mouse B lymphocytes, pointing out the critical
role of DC during the course of the humoral response, in-
cluding the following: (a) the demonstration that clusters of
helper T lymphocytes, histocompatible B cells, and DC
represented the site in which antibody-producing cells de-
velop during the response to thymus-dependent antigens in
vitro (11); (b) the observation that DC-oriented switch to-
wards IgA of normal mouse B lymphocytes or pre B cell
lines, stimulated with activated T cells or LPS (30, 31).
However, potential direct effects of DC on B cells (in addi-
tion to effects on activated T cells) have never been stud-
ied. To address this question, CD40L L cells were used as
surrogate activated T cells and DC were derived from cord
blood CD341 hematopoietic progenitors cultured for 12 d
in the presence of GM-CSF plus TNF-a (D–Lc) (18, 21).
CD1a1 D–Lc strongly enhance, in absence of any exogenous
cytokines, CD40-dependent B cell proliferation (2–6-fold
increase of viable cells) as well as differentiation (10–125-
fold increase of Ig secretion, depending on the isotype).
This striking direct effect of CD1a1 D–Lc on Ig secretion
was restricted to memory B cells. Furthermore, in the pres-
ence of IL-2, which by itself has only limited effects on in
vitro CD40-dependent B cell activation (8, 32, 33) D–Lc
stimulate resting naive IgD1 B cells to secrete large amounts
of IgM.
The direct modulation of B cell activation by D–Lc, un-
der CD40 triggering, reported here, suggests an important
role of the latter cells during secondary immune responses
(reactivation of memory B cells) and in the initiation of pri-
mary humoral responses (activation of naive B cells) and
should actually be discussed in the context of a series of per-
tinent in vitro and in vivo observations: (a) CD40 engage-
ment of cultured DC (20) yields cells with features of IDC
(including low CD1a as well as high CD25, CD80, and
CD86), which are found in the extrafollicular areas of sec-
ondary lymphoid organs (34–36); (b) antigen-induced T cell–
dependent B cell activation and differentiation into plasma
cells occurs within extrafollicular areas during both primary
(naive B cells) and secondary (memory B cells) humoral re-
sponses (16, 37, 38); (c) after antigenic challenge, CD40L-
expressing T cells are mainly found within periarteriolar
lymphatic sheaths (39), thus indicating that CD40-depen-
dent activation of DC may occur within the extrafollicular
areas of secondary lymphoid organs; (d) the IL-2 require-
ment for naive B cells to produce IgM is consistent with
immunohistochemical studies showing, after immuniza-
tion, the colocalization of CD40L1 IL-2 producing CD41
T cells and specific antibody-secreting B cells in the ex-
trafollicular areas of secondary lymphoid organs (39–41). In
keeping with this, in vitro studies have shown IL-2 to be
an important factor of primary humoral response (42–44).
In particular, recently activated CD41 T cells generate ef-
fector T cells that secrete mainly IL-2 and induce B cells to
secrete essentially IgM (44).
The mechanisms by which D–Lc regulate B cell re-
Figure 6. D–Lc enhance both proliferation and dif-
ferentiation of B cells activated with a soluble form of
CD40L. A soluble form of CD40L (sCD40L) was ex-
pressed as a dimeric fusion protein between the
mouse CD8a and the human CD40L. sCD40L was
used as a supernatant of COS cells at a final concen-
tration of 25% (right) to stimulate (A) B cell prolifera-
tion (104 cells per well) and (B) B cell differentiation
(104 cells per well). IL-2 and IL-10 were added at
concentration indicated in Materials and Methods.
Results obtained with CD40L L cells are indicated for
comparison (left). (results from 1 experiment repre-
sentative of 3). No significant B cell proliferation and
differentiation was observed in absence of CD40 en-
gagement.948 Functions of Dendritic Cells on B Cells
Figure 7. CD40-activated B cells are in close contact with D–Lc in coculture. 105 highly purified B cells were cultured in 24-well plates over 2.5 3
104 irradiated CD40L L cells and 5 3 104 D–Lc. After 8 d of coculture, cells were gently harvested, cytocentrifuged, and used for (A) MGG staining, (B)
anti-HLA-DR staining, (C) anti-CD80 (B7-1) staining, and (D) double anti-HLA-DR (red) and anti-CD20 (blue) staining (as detailed in Materials and
Methods). Magnification, 3400 (A, B, C); 31000 (D).949 Dubois et al.
sponses is not yet totally elucidated. However, the fact that
D–Lc stimulate the proliferation of IgD1 naive B cells
without altering their Ig secretion indicate that D–Lc affect
the growth and the differentiation of B cells through differ-
ent mechanisms and suggest the contribution of several mo-
lecular entities. Furthermore, TranswellsÒ experiments show
that D–Lc enhance growth of CD40-activated B cells through
the production of soluble factor(s) independently of CD40
triggering. In contrast, the effect on IgM secretion in the
presence of IL-2 is partly dependent on the release by D–Lc
of soluble mediator(s) after CD40 engagement. Among
known soluble mediators, IL-10, which has been shown to
act in synergy with IL-2 to induce strong B cell differentia-
tion (45), was excluded using MAbs (data not shown). The
mechanism of induction of IL-2 responsiveness is not yet
clear. As D–Lc expressed CD25 after CD40 engagement
(20), IL-2 could signal D–Lc, which in turn induce B cells
to produce IgM. Alternatively, such an effect might be due
to the ability of D–Lc to upregulate CD25 expression on
CD40-activated naive B cells (data not shown).
Together with the above considerations, our results em-
phasize the importance of a three-party cellular interaction,
where DC allow the encounter and interaction of antigen-
specific T cells with antigen-specific B cells during primary
humoral responses. First, DC, homing into the T cell–rich
areas, present processed antigen to naive T cells, through an
MHC–TCR interaction, resulting in upregulation of CD40L
on the T cell. In return, the activated T cell stimulates the
DC through CD40, resulting in CD80 and CD86 upregu-
lation and cytokine production (20). Then, the triggering
of CD28 on the T cell, in the presence of DC-derived
cofactors induces a full T cell activation followed by IL-2
production. Second, these reciprocal DC–T cell interac-
tions are likely to occur concomitantly with cognate T–B cell
interactions. Antigen-specific B cells, through CD40 en-
gagement and T cell–derived IL-2 differentiate into IgM-
secreting plasma cells, after close contact with DC previously
activated through CD40. There is presently no evidence
that DC present unprocessed antigen to B lymphocytes di-
rectly, though it is tempting to speculate that they may use
surface Fc receptors to carry the antigens in the form of im-
mune complexes or use lectins such as DEC 205 (46) or the
mannose receptor (47) to present unprocessed antigen to
specific B cells.
As a conclusion, the present results demonstrate that DC
can directly modulate CD40-dependent B cell activation,
suggesting that the critical role of DC in initiation of
T-dependent humoral response might be related to direct
modulation of B cell responses in the extrafollicular areas of
lymphoid organs.
Figure 8. The secretion of IgM by B cells is dependent on the produc-
tion of soluble factor(s) by D–Lc after CD40 engagement. 1.5 3 104
sIgD1 B cells were cultured in the presence of 3.75 3 103 CD40L L cells
or CD32 control L cells in the top of the transwell. 105 D–Lc were cul-
tured in the lower compartment with 2.5 3 104 CD40L L cells or CD32
L cells used as controls. (A) DNA synthesis of B cells of the upper com-
partment, in absence of cytokine, was determined after 6 d of coculture.
(B) IgM production in the presence of IL-2 was determined by ELISA af-
ter 15 d. Cultures were carried out in triplicates (one experiment repre-
sentative of three).
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